This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...